Compounds > sulfamethoxypyridazine
Page last updated: 2024-11-04

sulfamethoxypyridazine and Leprosy, Borderline

sulfamethoxypyridazine has been researched along with Leprosy, Borderline in 1 studies

Sulfamethoxypyridazine: A sulfanilamide antibacterial agent.
sulfamethoxypyridazine : A sulfonamide consisting of pyridazine having a methoxy substituent at the 6-position and a 4-aminobenzenesulfonamido group at the 3-position.

Leprosy, Borderline: A form of LEPROSY in which there are clinical manifestations of both principal types (lepromatous and tuberculoid). The disease may shift toward one of these two polar or principal forms.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Constant-Desportes, M1
Guelpa-Lauras, CC1
Carolina, JC1
Léoture, A1
Grosset, JH1
Sansarricq, H1

Other Studies

1 other study available for sulfamethoxypyridazine and Leprosy, Borderline

ArticleYear
A case of relapse with drug-susceptible M. leprae after multidrug therapy.
    International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 1991, Volume: 59, Issue:2

    Topics: Adult; Dapsone; Drug Therapy, Combination; Humans; Leprosy, Borderline; Leprosy, Lepromatous; Male;

1991